KESTRA MEDICAL TECHNOLOGIES (KMTS:NASDAQ)
$26.57 -0.35 (-1.3001%)
Analysed KESTRA MEDICAL TECHNOLOGIES (KMTS:NASDAQ) News Sources
Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2026 Financial Results
14-07-2026
yahoo.com
Kestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financing
14-07-2026
yahoo.com
Kestra Medical Technologies, Ltd. (KMTS) Reports Q4 Loss, Tops Revenue Estimates
14-07-2026
yahoo.com
Kestra Medical Technologies Q4 Earnings Call Highlights
14-07-2026
marketbeat.com
Kestra Medical Technologies Ltd (KMTS) Q4 2026 Earnings Call Highlights: Record Revenue Growth ...
15-07-2026
yahoo.com
KESTRA MEDICAL TECHNOLOGIES, LTD. Q4 2026 Earnings Call Summary
15-07-2026
moby.co
Strength Seen in Kestra Medical Technologies, Ltd. (KMTS): Can Its 8.1% Jump Turn into More Strength?
05-08-2026
yahoo.com
Apple downgraded, HPE upgraded: Wall Street's top analyst calls
10-08-2026
yahoo.com
Kestra Appoints Curtis Kopf as Senior Vice President of Customer Experience
26-08-2026
yahoo.com
Phibro Animal Health (PAHC) Tops Q4 Earnings and Revenue Estimates
26-08-2026
yahoo.com
What is the current price of KESTRA MEDICAL TECHNOLOGIES (KMTS:NASDAQ)?
The current price of KESTRA MEDICAL TECHNOLOGIES (KMTS:NASDAQ) is $26.57.
KESTRA MEDICAL TECHNOLOGIES (KMTS:NASDAQ) absolute price change since previous trading day?
The absolute price change of KESTRA MEDICAL TECHNOLOGIES (KMTS:NASDAQ) since the previous trading day is $-0.35.
KESTRA MEDICAL TECHNOLOGIES (KMTS:NASDAQ) percentage price change since previous trading day?
The percentage price change of KESTRA MEDICAL TECHNOLOGIES (KMTS:NASDAQ) since the previous trading day is -1.3001%.
What is the most recent average sentiment score for KESTRA MEDICAL TECHNOLOGIES (KMTS:NASDAQ)?
The most recent average sentiment score for KESTRA MEDICAL TECHNOLOGIES (KMTS:NASDAQ) is 58 out of 100.
What is the most recent average sentiment for KESTRA MEDICAL TECHNOLOGIES (KMTS:NASDAQ)?
The most recent sentiment for KESTRA MEDICAL TECHNOLOGIES (KMTS:NASDAQ) is .
SEC-8K** Filing Available For KESTRA MEDICAL TECHNOLOGIES (KMTS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.